Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05QMJ
|
||||
Former ID |
DNC014733
|
||||
Drug Name |
RWJ-56423
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Asthma [ICD10:J45] | Discontinued in Phase 1 | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C20H26N6O4S
|
||||
Canonical SMILES |
CC(=O)N1CC(CC1C(=O)NC(CCCN=C(N)N)C(=O)C2=NC3=CC=CC=C3S2<br />)O
|
||||
InChI |
1S/C20H26N6O4S/c1-11(27)26-10-12(28)9-15(26)18(30)24-14(6-4-8-23-20(21)22)17(29)19-25-13-5-2-3-7-16(13)31-19/h2-3,5,7,12,14-15,28H,4,6,8-10H2,1H3,(H,24,30)(H4,21,22,23)/t12-,14+,15+/m1/s1
|
||||
InChIKey |
VXDAVYUFYPFGDX-SNPRPXQTSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Trypsin | Target Info | Inhibitor | [2] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Pancreatic secretion | |||||
Protein digestion and absorption | |||||
Influenza A | |||||
Reactome | Activation of Matrix Metalloproteinases | ||||
Cobalamin (Cbl, vitamin B12) transport and metabolism | |||||
WikiPathways | Activation of Matrix Metalloproteinases | ||||
References | |||||
REF 1 | Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone. J Med Chem. 2003 Aug 28;46(18):3865-76. | ||||
REF 2 | J Med Chem. 2004 Feb 12;47(4):769-87.Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.